Abstract
In this chapter, I will briefly summarize the Stanford experience in the development of cardiac monitoring strategies for patients receiving anthracyclines.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mason J. 1978. Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol 41:887.
Bristow MR, Mason JW, Billingham ME, Daniels JR. 1978. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med 88:168.
Bristow MR, Billingham ME, Mason JW, Daniels JR. 1978. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 62:873.
Billingham ME, Bristow MR, Glatstein E, Mason JW, Masek M, Daniels JR. 1977. Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol 1:17.
Billingham ME, Hason JW, Bristow MR, Daniels JR. 1978. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep 62:865.
Billingham ME, Bristow MR. In press. Endomyocardial biopsy for cardiac monitoring of patients receiving anthracycline. In Endomyocardial biopsy: techniques and applications. Fenoglio J, ed. C.R.C. Press.
Bristow MR, Lopez MB, Mason JW, Billingham ME, Winchester MA. In press. Efficacy and cost of cardiac monitoring in patients receiving doxorubicin. Cancer.
Alexander J, Dainiak N, Berger HJ et al. 1979. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. New Engl J Med 300:278.
Bristow M, Lopez M, McKillop J. 1980. Specificity and sensitivity of radionuclide ejection fractions in doxorubicin cardiomyopathy. Proc AACR/ASCO 21:154.
Mason JW, Bristow MR, Billingham ME, Daniels JR. 1978. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep 62:857.
Bristow MR, Mason JW, Billingham ME, Daniels JR. 1981, in press. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J.
Henderson IC, Frei E. 1980. Adriamycin cardiotoxicity. Am Heart J 99:671.
Young RC, Ozols RF, Hyers CE. 1981. The anthracvcline antineoplastic drugs. New Engl J Med 305:139.
Choi W, Berger H, Alexander J et al. 1981. Serial radionuclide assessment of doxorubicin cardiotoxicitv in Cancer patients with abnormal baseline resting left ventricular performance. Am J Cardiol 47:474.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Bristow, M.R. (1982). Cardiac Monitoring of Patients Receiving Anthracyclines. In: Muggia, F.M., Young, C.W., Carter, S.K. (eds) Anthracycline Antibiotics in Cancer Therapy. Developments in Oncology, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7630-6_31
Download citation
DOI: https://doi.org/10.1007/978-94-009-7630-6_31
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7632-0
Online ISBN: 978-94-009-7630-6
eBook Packages: Springer Book Archive